Publication | Closed Access

The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy

Drug SafetyEmetogenic ChemotherapyOncologyChemotherapy-induced NauseaMedicinePharmacotherapyPharmacologyAdverse Drug Reaction